You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 4, 2024

CLINICAL TRIALS PROFILE FOR HYDROCHLOROTHIAZIDE; MOEXIPRIL HYDROCHLORIDE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for hydrochlorothiazide; moexipril hydrochloride

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00834067 ↗ Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions Completed Teva Pharmaceuticals USA Phase 1 2003-10-01 The objective of this study is to compare the relative bioavailability of moexipril HCl/ hydrochlorothiazide 15/25 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of UNIRETIC® 15/25 mg tablets (Schwartz Pharma) in healthy, adult, non-smoking subjects under non-fasting conditions.
NCT00835042 ↗ Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions Completed Teva Pharmaceuticals USA Phase 1 2003-10-01 The objective of this study is to compare the relative bioavailability of Moexipril HCl/hydrochlorothiazide 15/25 mg tablets (manufactured and distributed by TEVA Pharmaceuticals USA) with that of UNIRETIC® 15/25 mg tablets (Schwartz Pharma) in healthy, adult non-smoking subjects under fasting conditions.
NCT00990301 ↗ A Study to Compare the Relative Bioavailability of Moexipril HCl/Hydrochlorothiazide in Healthy Adult Volunteers Under Fasting Conditions Completed Paddock Laboratories, Inc. Phase 1 1969-12-31 The purpose of this study was to evaluate the relative bioavailability of Paddock Laboratories, Inc.'s test formulation of Moexipril/ Hydrochlorothiazide 15mg/25mg tablets with a reference formulation Uniretic®(Moexipril/ Hydrochlorothiazide) 15mg/25mg tablets, under fasting conditions.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for hydrochlorothiazide; moexipril hydrochloride

Condition Name

Condition Name for hydrochlorothiazide; moexipril hydrochloride
Intervention Trials
Healthy 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for hydrochlorothiazide; moexipril hydrochloride
Intervention Trials
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for hydrochlorothiazide; moexipril hydrochloride

Trials by Country

Trials by Country for hydrochlorothiazide; moexipril hydrochloride
Location Trials
United States 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for hydrochlorothiazide; moexipril hydrochloride
Location Trials
Texas 2
Missouri 2
Pennsylvania 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for hydrochlorothiazide; moexipril hydrochloride

Clinical Trial Phase

Clinical Trial Phase for hydrochlorothiazide; moexipril hydrochloride
Clinical Trial Phase Trials
Phase 1 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for hydrochlorothiazide; moexipril hydrochloride
Clinical Trial Phase Trials
Completed 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for hydrochlorothiazide; moexipril hydrochloride

Sponsor Name

Sponsor Name for hydrochlorothiazide; moexipril hydrochloride
Sponsor Trials
Teva Pharmaceuticals USA 2
Paddock Laboratories, Inc. 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for hydrochlorothiazide; moexipril hydrochloride
Sponsor Trials
Industry 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.